Advances in molecular preclinical therapy mediated by imaging(67 visite)(PDF pubblico86 visite) Greco A, Albanese S, Auletta L, De Carlo F, Salvatore M, Howard CM, Claudio PP
Q J NUCL MED MOL IM (ISSN: 1824-4785), 2017 Mar; 61(1): 76-94.
Tipo di articolo: Journal Article, Review,
Impact factor: 2.368, Impact factor a 5 anni: 2.029
Url: Non disponibile.
Parole chiave: Animals, Diagnostic Imaging, Methods, Drug Delivery Systems, Humans, Neoplasms, Therapy, Precision Medicine,
Affiliazioni:
*** IBB - CNR *** Department of Advanced Biomedical Science, University of Naples Federico II, Naples, Italy., Ceinge, Advanced Biotechnology, Scarl, Naples, Italy., Institute of BioStructures and BioImaging, CNR, Naples, Italy., IRCCS SDN, Naples, Italy., Department of BioMolecular Sciences, National Center for Natural Products Research, University of Mississippi, Jackson, MS, USA., Department of Radiology, University of Mississippi Medical Center, Jackson, MS, USA., Department of BioMolecular Sciences, National Center for Natural Products Research, University of Mississippi, Jackson, MS, USA - pclaudio@olemiss.edu., Department of Radiation Oncology, Medical Center Cancer Institute, Jackson, MS, USA.,
Riferimenti:
Non disponibile.
Several advances have been made toward understanding the biology of cancer and most of them are due to robust genetic studies that led to the scientific recognition that although many patients have the same type of cancer their tumors may have harbored different molecular alterations. Personalized therapy and the development of advanced techniques of preclinical imaging and new murine models of disease are emerging concepts that are allowing mapping of disease markers in vivo and in some cases also receptor targeted therapy. Aim of this review is to illustrate some emerging models of disease that allow patient tumor implantation in mice for subsequent drug testing and advanced approaches for therapy mediated by preclinical imaging. In particular we discuss targeted therapy mediated by high frequency ultrasound and magnetic resonance, two emerging techniques in molecular preclinical therapy.
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(20 visite) NEW ENGL J MED (ISSN: 0028-4793), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 DettagliEsporta in BibTeXEsporta in EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(143 visite) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 DettagliEsporta in BibTeXEsporta in EndNote
368 Records (343 escludendo Abstract e Conferenze). Impact factor totale: 1217.469 (1135.195 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 1269.152 (1171.27 escludendo Abstract e Conferenze).
ibb.cnr.it